oscillations increased, the extent of contraction increased. ET-induced contraction was also associated with an increase in Ca 2ϩ sensitivity. In "model" slices in which the [Ca 2ϩ ]i was constantly maintained at an elevated level by pretreatment of slices with caffeine and ryanodine, the addition of ET increased bronchiole and arteriole contraction. These results indicate that ET-induced contraction of bronchiole and arteriole SMCs is regulated by the frequency of Ca 2ϩ oscillations and by increasing the sensitivity of the contractile machinery to Ca 2ϩ .
sensitivity regulate SMC contraction, we have studied mouse lung slices with phase-contrast and confocal microscopy to correlate the ET-induced contraction with the changes in [Ca 2ϩ ]i and Ca 2ϩ sensitivity of bronchiole and arteriole SMCs. In comparison with acetylcholine (ACh) or serotonin (5-HT), ET induced a stronger and long-lasting contraction of both bronchioles and arterioles. This ETinduced contraction was associated with prominent asynchronous Ca 2ϩ oscillations that were propagated as Ca 2ϩ waves along the SMCs. These Ca 2ϩ oscillations were mediated by cyclic intracellular Ca 2ϩ release and required external Ca 2ϩ for their maintenance. Importantly, as the frequency of the Ca 2ϩ oscillations increased, the extent of contraction increased. ET-induced contraction was also associated with an increase in Ca 2ϩ sensitivity. In "model" slices in which the [Ca 2ϩ ]i was constantly maintained at an elevated level by pretreatment of slices with caffeine and ryanodine, the addition of ET increased bronchiole and arteriole contraction. These results indicate that ET-induced contraction of bronchiole and arteriole SMCs is regulated by the frequency of Ca 2ϩ oscillations and by increasing the sensitivity of the contractile machinery to Ca 2ϩ .
confocal microscopy; blood vessels; airways; lung slices; acetylcholine; serotonin THE PRESENCE OF ENDOTHELIN-1 (ET) within the lung and its ability to induce SMC contraction (6, 16, 25) , SMC proliferation (23, 39) , and proinflammatory cytokine release (13) has led to the suggestion that ET contributes to the development of a variety of lung diseases (14) . These include pulmonary arterial hypertension, which results from an increase of pulmonary vascular resistance and leads to heart failure (37) , and asthma, which results from excessive contraction of airway SMCs and is associated with inflammation (10) . Although ET within the lung is mainly synthesized and secreted by vascular endothelial cells of blood vessels (33, 54) , the epithelial cells of the major airways (tracheal and bronchi) (15, 30, 46) and the airway SMCs themselves (15, 51) also produce ET. With respect to asthma, these sources may be particularly important, because ET synthesis and release is increased in response to challenges with histamine and cytokines that are typically associated with airway hyperresponsiveness (6, 14) . Other sources of ET are alveolar type II cells (8) and macrophages (27) .
The intracellular signaling cascade induced by ET to activate SMC contraction is not fully understood. Briefly, ET can act at the cell membrane via one or both of two G protein-coupled ET receptor subtypes (ET A and ET B ) to increase phospholipase C (PLC) activity (34) . This, in turn, produces inositol 1,4,5-trisphosphate (IP 3 ) to stimulate an elevation of intracellular Ca 2ϩ (11, 43 ) that leads to the activation of myosin light chain kinase (MLCK) to initiate actin-myosin cross-bridge cycling and SMC contraction.
Although previous studies have shown that ET induces Ca 2ϩ increases in isolated SMCs, these Ca 2ϩ increases occurred as simple biphasic signals consisting of an initial transient increase in Ca 2ϩ followed by a sustained plateau (26, 36) . By contrast, we and others have recently found, with the advantages of high temporospatial resolution provided by confocal microscopy, that G protein-coupled receptor agonists such as serotonin (5-HT), acetylcholine (ACh), and ATP induce repetitive Ca 2ϩ oscillations rather than static increases in Ca 2ϩ in airways (4, 28, 42, 44, 45) and arterioles (35, 41) . Because the frequency of these Ca 2ϩ oscillations is dependent on both agonist type and concentration and correlates with SMC contraction, we initially believed that the frequency of these Ca 2ϩ oscillations regulates the magnitude of bronchiole and arteriole SMC contraction (41, 42) . However, our subsequent studies clearly indicate that SMC contraction in lung slices (3) can be also regulated by a mechanism known as Ca 2ϩ sensitivity (18, 50) . In this study, we investigate the relative contribution of Ca 2ϩ oscillations and Ca 2ϩ sensitivity to SMC contraction induced by ET in living lung slices. This understanding of the mechanisms regulating ET-initiated SMC contraction will significantly facilitate our search for therapeutic approaches to treat lung diseases.
MATERIALS AND METHODS
All the materials and methods used have been previously described in detail (42) ; only a brief outline is given. Reagents were obtained either from Invitrogen Life Technologies-GIBCO (Carlsbad, CA) or Sigma (St. Louis, MO). ET (E-7764) was obtained from Sigma. Hanks' balanced salt solution was supplemented with 20 mM HEPES buffer (sHBSS). Hanks' 0-Ca 2ϩ solution was prepared by supplementing sHBSS without Ca 2ϩ and Mg 2ϩ with 0.9 mM MgSO4 and 1 mM Na 2H2-EGTA. Bosentan sodium salt was a gift from Actelion Pharmaceuticals (Allschwil, Switzerland). A stock solution of bosentan was prepared at 1 mM in water on the same day of use.
Lung slices. Lung slices were prepared from BALB/C mice between 7 and 10 wk old. The trachea was cannulated with an intravenous catheter, and after the chest cavity was opened, the collapsed lungs were reinflated with 1.3 Ϯ 0.1 ml of 2 % agarose (low-gelling temperature) in sHBSS, followed by the injection of 0.2 Ϯ 0.1 of air to flush the agarose-sHBSS out of the airways and into the distal alveolar space. Subsequently, a warm (37°C) solution of gelatin (type A, porcine skin, 300 bloom, 6% in sHBSS) was perfused through the intrapulmonary blood vessels via the pulmonary artery by injecting ϳ0.3 ml into the right ventricle. The warm agar and gelatin were gelled with cold sHBSS. A single lung lobe was removed and cut into serial sections of ϳ130 m thick with a vibratome at ϳ4°C, starting at the lung periphery. Slices were maintained in DMEM (Invitrogen) at 37°C and 10% CO2 for up to 3 days. Serum was not used, because it contains 5-HT and growth factors (1) . At 37°C, the gelatin in the blood vessel lumen dissolved, leaving the blood vessel lumen empty. Only lung slices that had both a bronchiole and an accompanying arteriole with a well-defined lumen were selected for the experiments. No significant changes in the contractility of bronchioles and arterioles in response to stimulation with 1 M 5-HT were detected during the first 48 h of culture; therefore, for these experiments we used slices maintained for Ͻ48 h.
Measurement of the contractile response of bronchioles and arterioles induced by agonists. Lung slices were mounted in a custommade perfusion chamber and held in place with a small sheet of nylon mesh. A second cover glass edged with silicone grease was placed over the lung slice. Perfusion of the lung slice was performed using a gravity-fed perfusion system. The volume of the chamber was ϳ100 l with a perfusion rate of ϳ800 l/min. For phase-contrast microscopy, the lung slice was observed with an inverted microscope with a ϫ10 objective, and images were recorded using a charge-coupled device camera and image acquisition software (Video Savant). Digital images were recorded in time lapse (30 frames/min). The area of the bronchiole and arteriole lumen was calculated, from each image, by pixel summing using custom-written software. Experiments were performed at room temperature.
Measurements of intracellular Ca 2ϩ . Approximately 10 -12 lung slices were incubated in 2 ml of 20 M Oregon green 488 BAPTA-1 AM, 100 M sulfobromophthalein (an inhibitor temporarily used to prevent dye extrusion through anion exchangers), and 0.2% Pluronic F-127 for 50 min at 30°C, followed by an additional 50 min at 30°C in sHBSS containing 100 M sulfobromophthalein. Lung slices were mounted in the perfusion chamber as described. Fluorescence imaging was performed using a video-rate confocal microscope (47) . Briefly, a 488-nm laser was used as the excitation wavelength. The resultant fluorescence (Ͼ510 nm) was detected by a photomultiplier tube and a frame capture board to form images that were recorded at 15 Hz. Changes in fluorescence intensity were analyzed by selecting regions of interest (ROI) of ϳ7 ϫ 7 pixels. Average fluorescence intensities of an ROI were obtained, frame by frame, using custom-written software that allowed the tracking of the ROI within a SMC as it moved with contraction. Final fluorescence values are expressed as a fluorescence ratio (F/F 0) normalized to the initial fluorescence (F0). Line-scan analysis of images was performed by extracting a line of pixels from each image and placing them sequentially, as a time sequence, in a single image.
Preparation of caffeine-ryanodine model slices. "Model" lung slices were prepared by exposing lung slices to 20 mM caffeine with 50 M ryanodine for 3-4 min, followed by a washout with sHBSS. This treatment locks the ryanodine receptors (RyR) 
RESULTS
Contractile potencies of ET, ACh, and 5-HT in bronchioles and arterioles. To establish the relative potency of ET as a contractile agonist for both the bronchioles and arterioles, we simultaneously compared the contractile responses of the bronchioles and arterioles in a lung slice sequentially stimulated with maximal concentrations of ACh and 5-HT (1 M) and with ET (10 nM) ( Fig. 1 and Supplemental Video 1). The agonists ET, ACh, and 5-HT induced bronchiole and arteriole contraction with different potencies and kinetics ( Fig. 1 ; Table 1 ). In the bronchiole, the contraction (measured after 8 min of stimulation) induced by ET was similar to or bigger than the contraction induced by ACh or 5-HT, respectively (Table 1 ). In the arteriole, ET and 5-HT induced contractions of similar magnitude ( Fig. 1; Table 1 ), whereas ACh had no effect. However, the contraction of bronchioles and arterioles induced by 10 nM ET was slower and had a longer onset time than the contraction induced by ACh or 5-HT (Table 1) . In contrast to the fast relaxation of bronchioles and arterioles following ACh and 5-HT removal, the relaxation following the washout of ET was extremely slow ( Fig. 1B; Table 1 ). This suggests a slower dissociation rate for ET than for ACh or 5-HT from their receptors.
Concentration dependence of bronchiole and arteriole contraction on ET. To determine the relative sensitivity of bronchioles and arterioles to ET, we measured the changes in lumen area in response to different concentrations of ET (Fig. 2) . However, because the contractile response of bronchioles and arterioles to ET was essentially irreversible, we used different lung slices for each ET concentration. To reduce experimental variation associated with different lung slices, ET stimulation was preceded by a calibration stimulation with 1 M 5-HT, and only slices responding to 5-HT with a reduction in bronchiole lumen area of 40 -60 % and arteriole lumen area of 60 -80 % were analyzed.
Bronchiole and arteriole contraction in response to 1 nM ET was characterized by a delayed onset (ϳ3 min after solution change) and a slow rate (maximal rate Ͻ1% lumen area/s) ( Fig. 2A) . The reduction in lumen area after 8 min of stimulation was 22 Ϯ 11% in bronchioles and 52 Ϯ 7% in arterioles (Fig. 2D ). Increasing concentrations of ET from 1 to 50 nM reduced the delay before contraction began and increased the rate of the contraction of both bronchioles and arterioles (Fig.  2 , A-C). The magnitude of the bronchiole and arteriole contraction increased with ET concentration from 1 to 10 nM but was maximal at concentrations Ͼ10 nM. At all concentrations of ET, the arteriole contraction was greater than the bronchiole contraction (Fig. 2D) . Collectively, the induction of strong and maximal contraction by low ET concentrations, the reduction of the onset time to contraction by increasing ET concentrations, and the slow relaxation upon ET removal indicated that ET stimulates contraction by a cumulative binding with high affinity to its receptors. Relationship between the frequency of Ca 2ϩ oscillations and contraction. When lung slices were stimulated with 10 nM ET, both the frequency of the Ca 2ϩ oscillations and the contraction of bronchiole and arteriole SMCs increased as a function of time (Fig. 5, A and B) . In bronchioles, the frequency of ET-induced Ca 2ϩ oscillations increased from 8.9 Ϯ 4.3 cycles/ min, at the beginning of the Ca 2ϩ response, to a sustained frequency of 26.5 Ϯ 3.0 cycles/min at 3 min after the onset of the Ca 2ϩ response (Fig. 5A ). The contraction of the bronchioles increased during 2-3 min until it began to plateau at ϳ50% (Fig. 5B) . The simultaneous correlation of the Ca 2ϩ oscillation frequency with contraction indicates that as the frequency of the Ca 2ϩ oscillations increased, there was a concomitant increase in bronchiole contraction (Fig. 5C) .
The frequency of the Ca 2ϩ oscillations in arteriole SMCs was significantly lower than in bronchiole SMCs and increased from 4.3 Ϯ 2.0 cycles/min at the beginning of the Ca 2ϩ response to 8.9 Ϯ 2.0 cycles/min at 3 min after the onset of the Ca 2ϩ response (Fig. 5A) . In contrast to the frequency of Ca 2ϩ oscillations, the contraction was significant larger in arterioles than in bronchioles. In addition, arteriole contraction increased quickly during the first minute of ET-stimulation before reaching a plateau with ϳ80 % contraction (Fig. 5B) . The simultaneous correlation of the Ca 2ϩ signaling and contraction in arteriole SMCs showed two phases (Fig. 5C) . In phase 1, there (4) . B: change in cross-sectional area of the lumen of the bronchiole (solid line) and arteriole (shaded line) with respect to time in response to ACh, 5-HT, and ET as indicated. ACh induced contraction of the bronchiole but not the arteriole. The apparent increase in arteriole lumen size resulted from passive stretching by the contraction of the airway. 5-HT and ET induced contraction of both the bronchiole and arteriole. After washout of ACh and 5-HT with Hanks' balanced salt solution supplemented with 20 mM HEPES buffer (sHBSS), the contraction of the bronchiole and the arteriole was quickly relaxed; however, after washout of ET, the bronchiole only relaxed very slowly, whereas the arteriole showed no relaxation. A representative experiment selected from 6 different slices from 3 mice. A movie of these data is shown in Supplemental Video 1.
was a concomitant increase in the frequency of the Ca 2ϩ oscillations and the contraction (up to ϳ50%). Subsequently, in phase 2, the arteriole continued to contract an additional ϳ25% even though the frequency of Ca 2ϩ oscillations slowed before resuming with a small increase in frequency.
This temporal correlation between the Ca 2ϩ oscillation frequency and the changes in bronchiole or arteriole lumen area suggests that bronchiole and arteriole SMC contraction is, in part, regulated by the frequency of the Ca 2ϩ oscillations. However, the relationship between Ca 2ϩ oscillation frequency and contraction was different for the bronchiole and arteriole SMCs. Over the same contraction range, the frequency of Ca 2ϩ oscillations was, in general, about three times faster in bronchiole SMCs than in arteriole SMCs (Fig. 5C ). These findings that bronchiole SMCs require faster Ca 2ϩ oscillation frequencies than arteriole SMCs to sustain ET-stimulated contraction and that arteriole contraction occurs in two phases suggests that the contraction is regulated by additional mechanisms besides just the frequency of Ca 2ϩ oscillations (see below (Fig. 6, B and  C) . However, the rate of relaxation was again slower in the arterioles than in the bronchioles.
In a reverse series of experiments, with lung slices preincubated (1 min) and maintained in Ca 2ϩ -free medium, ET triggered Ca 2ϩ oscillations and contraction in both bronchiole and arteriole SMCs. However, the Ca 2ϩ oscillations were not maintained (abolished after 2 min), and the bronchioles and arterioles relaxed (4 experiments from 3 mice; data not shown). Fig. 1 for contractile responses to endothelin-1 (ET), serotonin (5-HT), and acetylcholine (ACh). To determine the maximal rate of contraction, the first derivative of the change in lumen area vs. time ͓Ϫd(lumen area)/dt͔ was determined and the peak value (maximal rate) after addition of each agonist was obtained. For relaxation after agonist washout, data correspond to the increase in lumen area divided by the contracted lumen area measured at 8 min after stimulation. *P Ͻ 0.05 vs. values from 5-HT and ACh (bronchioles) or 5-HT (arterioles). ] i was attained in both bronchiole (Fig. 7A ) and arteriole SMCs (Fig. 7B) . Simultaneous recordings of Ca 2ϩ and contraction indicated that although CPA inhibit the dynamic Ca 2ϩ signaling, the sustained Ca increase continued to induced an additional small increase in contraction in both bronchioles and arterioles (Fig. 7) . The subsequent removal of extracellular Ca 2ϩ reduced the [Ca 2ϩ ] i to a level lower than that of the unstimulated cell, and this was accompanied by a fast relaxation of bronchioles but a slower relaxation of arterioles. These changes in [Ca 2ϩ ] i and contraction were reversed by the readdition of Ca 2ϩ to the extracellular medium (Fig. 7) . Collectively, these results and those from experiments in Ca 2ϩ -free medium (Fig. 6) suggest that ET-induced Ca 2ϩ oscillations in both bronchiole and arteriole SMCs resulted from Ca 2ϩ release from SR but required some Ca 2ϩ influx to sustain their activity. Ca 2ϩ sensitization induced by ET. Because we found that bronchiole and arteriole contractility did not appear to be simply proportional to the Ca 2ϩ oscillation frequency, we investigated the effect of ET on the Ca 2ϩ sensitivity of the bronchiole and arteriole contraction with caffeine-ryanodine model slices. Figure 8 shows the changes in [Ca 2ϩ ] i and contraction of the bronchiole and arteriole in response to control stimulation with 5-HT during the establishment of the caffeine-ryanodine model slice and the subsequent responses to ET.
In response to 5-HT, the bronchiole and arteriole showed typical Ca 2ϩ oscillations and contraction (Fig. 8, A-C) . Addi- tion of caffeine plus ryanodine induced a transient increase in [Ca 2ϩ ] i followed by a sustained increase in [Ca 2ϩ ] i in both bronchiole (Fig. 8A ) and arteriole SMCs (Fig. 8B) . This response is consistent with the expected initial Ca 2ϩ release from internal Ca 2ϩ stores followed by a sustained influx of Ca 2ϩ (3). However, the bronchiole and arteriole only contracted transiently in response to caffeine plus ryanodine (Fig. 8, A-C) . This is consistent with the relaxing effect of caffeine on SMCs. After washout of the caffeine and ryanodine, the [Ca 2ϩ ] i remained elevated (Fig. 8, A and B) , but the contractile response to the sustained [Ca 2ϩ ] i elevation was significantly different between bronchioles and arterioles (Fig. 8C) . The bronchioles either remained relaxed or only showed a small recontraction (6 Ϯ 4% of their initial area), whereas the arterioles strongly recontracted (55 Ϯ 9% of their initial area). The subsequent addition of ET to model slices did not induce a change in [Ca 2ϩ ] i but initiated a strong contraction of the bronchioles (66 Ϯ 9%) and a further contraction of the arterioles (41 Ϯ 7%) (Fig. 8, A-C) . Bronchiole and arteriole contractions were abolished by subsequent removal of extracellular Ca 2ϩ (Fig. 8, A and B ). These results demonstrate that arterioles are inherently much more sensitive to Ca 2ϩ than bronchioles and that although ET increases the Ca 2ϩ sensitivity of both bronchiole and arteriole SMCs, ET-induced Ca 2ϩ sensitization is essential for bronchiole contraction.
Type of ET receptors. To investigate the type of the ET receptors that mediates the ET-induced contraction of bronchioles and arterioles, we compared the inhibitory effects of the selective ET A and ET B receptor antagonists BQ-123 and BQ-788, respectively, and the nonselective ET receptor antagonist bosentan on the contractile response to ET (Fig. 9) In all experiments, a prestimulation with 5-HT was used to calibrate the bronchiole and arteriole responses in different slices. Compared with the control stimulation with 5 nM ET (Fig. 9A) , all antagonists inhibited the ET-induced contractile response of bronchioles and arterioles by delaying the onset, slowing the rate, and reducing the magnitude of the contraction (Fig. 9,  B-D) . However, each antagonist inhibited the ET-induced contraction with a different potency. The rightward shift and decreased maxima of the concentration-contraction response (Fig. 9, E and F) indicate that BQ-788 and bosentan produced the strongest inhibitory effects on bronchioles and arterioles, respectively. By comparing the maximal contraction (⌬area max ) and the concentration of ET inducing one-half of ⌬area max (SC 50 ) for each antagonist (Table 2) , we established the following orders of potency: for bronchioles, BQ-788 Ͼ bosen- ET-induced bronchiole and arteriole contraction was inhibited by ET receptor blockers. E and F: summary of ET-induced bronchiole (E) and arteriole contraction (F) in the absence or presence of ET receptor blockers. Contraction was measured as the decrease in lumen area (5 min after ET stimulation) and normalized to the calibration contraction (measured after 8 min of 5-HT stimulation) in each experiment. Each point represents the mean Ϯ SE from at least 3 different experiments on different slices from at least 2 mice. The contractility data were fitted with logistic function curves, or data points were joined by a straight line.
tan Ͼ BQ-123; for arterioles, bosentan Ͼ BQ-788 ϭ BQ-123. These results suggest that ET-induced contraction of bronchioles is mediated by both ET A and ET B receptors with a preponderance of ET B receptors, whereas ET-induced contraction of the arterioles involves an equal participation of ET A and ET B receptors. These results are consistent with reported results for mouse bronchioles (38) and rat arterioles (17, 32) .
DISCUSSION
The anatomical proximity of the small bronchioles and arterioles in the lung allows the simultaneous measurements of bronchiole and arteriole contraction in lung slices using phasecontrast microscopy. This direct comparison of bronchiole and arteriole contraction is important for an integrative understanding of the effect of agonists such as ET. A unique advantage of thin lung slices is that agonist-induced contraction can also be simultaneously measured with the changes in [Ca 2ϩ ] i in individual bronchiole and arteriole SMCs. This simultaneous determination of Ca 2ϩ and contraction is crucial to understand how the dynamic changes in [Ca 2ϩ ] i in SMCs regulate the contraction of bronchioles and arterioles during agonists stimulation. In previous studies, we examined in detail the regulation of bronchiole and arteriole contraction by changes in Ca 2ϩ induced by ACh and 5-HT (41, 42) . In this study, we extended these studies to include ET, because ET is recognized as a potent endogenous constrictor producing long-lasting contraction of pulmonary blood vessels (7, 31) and tracheal or bronchial airways (2, 52) .
The contraction of the bronchioles and arterioles induced by ET was significantly different from the contraction induced by ACh and 5-HT. First, ET induced contractions at low concentrations; 10 nM ET produced a similar or stronger contraction than that induced by 1 M ACh or 5-HT. Second, ET induced contractions that had a delayed onset and occurred at a slow rate. Finally, ET induced long-lasting contractions that were resistant to reversal by washout. These properties of ETinduced contractions observed in small bronchioles and arterioles were similar to those observed in other pulmonary and nonpulmonary vascular beds (14) and are consistent with results from binding studies of ET to SMC membrane preparations from several SMC types (53) reporting that ET binds to its receptor with relative slow association and dissociation kinetic constants, resulting in a half-dissociation time (t 1/2 ) of ϳ165 h. Therefore, ET is known to be a pseudo-irreversible ligand of ET receptors (11) .
With confocal microscopy, we found that stimulation of lung slices with ET induced persistent and asynchronous Ca 2ϩ oscillations in both bronchiole and arteriole SMCs. These Ca 2ϩ oscillations correspond to repetitive intracellular Ca 2ϩ waves that originated at one point of the cell and propagated along the longitudinal axis of the SMC. However, this dynamic Ca 2ϩ signaling differs from the ET-induced Ca 2ϩ signaling observed in other studies using different airway and pulmonary artery preparations and other Ca 2ϩ detection techniques. For most tissue preparations, including strips of trachea (22), isolated rat trachea SMCs (36), cultured SMCs from human bronchi (40) , rat intrapulmonary arteries (49), or isolated SMCs from rabbit intrapulmonary arteries (26) , ET induced an initial transient increase in [Ca 2ϩ ] i that was usually followed by a sustained increase or plateau in [Ca 2ϩ ] i . The failure to resolve Ca 2ϩ oscillations in these studies was most likely due to the slow sampling speeds used to monitor the Ca 2ϩ changes. This is emphasized by the fact that when higher sampling speeds were used, ET was reported to induced a Ca 2ϩ transient followed by three to five oscillations of decreasing amplitude in rat SMCs isolated from the trachea (20) , pulmonary artery, and intrapulmonary arteries (19) . We believe our ability to observe sustained Ca 2ϩ oscillations within the SMCs with a maximal frequency of ϳ25 per minute results from two fundamental advantages: we sampled at a rate of 15 images/s, and, perhaps more importantly, we used a lung slice preparation that preserves many of the in situ characteristics of the lung tissue.
Although the spatial aspects of the ET-induced Ca 2ϩ oscillations in the bronchiole and arteriole SMCs were similar to the Ca 2ϩ oscillations induced by ACh and 5-HT (41, 42), the temporal characteristics were different. In bronchiole and arteriole SMCs, ACh or 5-HT induced Ca 2ϩ oscillations that occurred with a steady frequency. However, ET induced Ca 2ϩ oscillations in bronchiole and arteriole SMCs that had a frequency that was initially low but progressively increased for ϳ3 min before a sustained frequency was attained. This difference in Ca 2ϩ signaling may be explained by the difference in the kinetics of the agonists binding to their receptors. In contrast to ACh and 5-HT, ET binds to its receptors with slower kinetics but higher affinity (11) . Consequently, the perfusion of lung slices with a low concentration of ET would be predicted to progressively increase the number of activated ET receptors.
The progressive increase in the Ca 2ϩ oscillation frequency in bronchiole SMCs was correlated with a concomitant increase in bronchiole contraction. A similar correlation between the increase in Ca 2ϩ oscillation frequency and bronchiole contraction was observed during stimulation of lung slices with increasing concentrations of ACh or 5-HT (42) . This finding, together with data from other studies, has led to the hypothesis that contraction is regulated by the frequency of the Ca 2ϩ Maximal contraction (⌬areamax) and the concentration of ET inducing one-half of ⌬areamax (SC50) were measured in bronchioles and arterioles from data shown in Fig. 9 , E and F, respectively; n is the number of experiment in each condition. To correct for differences in bronchiole and arteriole contractility from different slices, ⌬areamax was normalized in each experiment to the calibration contraction, induced by stimulation with 5-HT (see Fig. 3, A-D) .
oscillations in airway SMCs (4, 28, 42) , pulmonary vascular SMCs (41) , and systemic vascular SMCs (29, 35, 48) .
The frequency of ET-induced Ca 2ϩ oscillations was approximately three times slower in arteriole (ϳ10 cycles/min) compared with bronchiole SMCs (ϳ30 cycles/min). A similar threefold difference in the Ca 2ϩ oscillation frequency between arteriole and bronchiole SMCs was observed for stimulation with 5-HT (41) . An explanation for the difference in the Ca 2ϩ oscillation frequency between SMCs types could be due to differences in receptor activation or the signal transduction mechanism linking receptor activation to the generation of Ca 2ϩ oscillations. The similarity of the Ca 2ϩ oscillation frequencies of arteriole and bronchiole SMCs in response to two different agonists (ET and 5-HT) suggests that the difference lies with the coupling of receptor activation to the generation of Ca 2ϩ oscillations. However, the identity of this difference is beyond the scope of the present study.
The most likely mechanism utilized for the generation of ET-induced Ca 2ϩ oscillations is agonist activation of G protein-coupled ET receptors, which in turn stimulate PLC activity to synthesize IP 3 (11, 43 (21, 55) and porcine (9) ␣-toxin-permeabilized tracheal strips. However, in these studies, high [Ca 2ϩ ] i itself induced a strong airway contraction. This result, although contrary to our observations, could be related to differences in the contractile properties between trachea and bronchial airways or between species. Other possible explanation may related to the loss of intracellular components during the membrane permeabilization with ␣-toxin. In our model slices, the Ca 2ϩ permeability of the plasma membrane was increased by emptying the Ca 2ϩ stores, but the integrity of the membrane was preserved. A similar absence of bronchiole contraction induced by high [Ca 2ϩ ] i has been observed in a prior study in our laboratory, and sensitization of bronchiole SMC contraction to Ca 2ϩ was observed with methacholine (3). This study concluded that the lack of a sustained contraction of bronchioles in presence of high [Ca 2ϩ ] i was the result of a Ca 2ϩ -induced relaxation (Ca 2ϩ desensitization) that is antagonized by stimulation with the agonist (Ca 2ϩ sensitization). In contrast to the bronchioles, high [Ca 2ϩ ] i within the arterioles produced sustained arteriole contraction in model slices, and the subsequent addition of ET induced an additional arteriole contraction without changes in [Ca 2ϩ ] i , indicating increased Ca 2ϩ sensitization. ET-induced Ca 2ϩ sensitization was also observed in ␣-toxin-permeabilized rat pulmonary artery rings (12) . Although the mechanism of ET-induced Ca 2ϩ sensitization is beyond the scope this work, a likely explanation for the increase in contraction at a constant [Ca 2ϩ ] i is an increase in phosphorylation of the myosin light chain (MLC) due to ET-induced inactivation of the MLC phosphatase. In support of this hypothesis, increases in force at constant [Ca 2ϩ ] i were correlated with increases in MLC phosphorylation in ␣-toxin-permeabilized rat pulmonary artery rings during ET-stimulation (12) and in canine tracheal strips during ACH stimulation (24) .
In conclusion, ET is a powerful agonist in the lung, inducing a potent and sustained contraction of intrapulmonary bronchioles and arterioles. ET-induced contraction is mediated by activation of both ET A and ET B receptors to generate Ca 2ϩ oscillations. The frequency of the Ca 2ϩ oscillations, in combination with Ca 2ϩ sensitization of SMC contraction, induced by ET serves as a mechanism to regulate SMC contraction. This understanding of how Ca 2ϩ signaling regulates SMC contraction is essential to the search for therapeutic approaches to asthma and hypertension.
